Eloxx Pharmaceuticals Stock Revenue
ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Eloxx Pharmaceuticals fundamentals help investors to digest information that contributes to Eloxx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Eloxx Pink Sheet. The fundamental analysis module provides a way to measure Eloxx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eloxx Pharmaceuticals pink sheet.
Eloxx |
Eloxx Pharmaceuticals Company Revenue Analysis
Eloxx Pharmaceuticals' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Eloxx Pharmaceuticals reported 0.0 of revenue. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Eloxx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eloxx Pharmaceuticals' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eloxx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eloxx Pharmaceuticals by comparing valuation metrics of similar companies.Eloxx Pharmaceuticals is currently under evaluation in revenue category among its peers.
Eloxx Fundamentals
Return On Equity | -6.15 | ||||
Return On Asset | -0.73 | ||||
Current Valuation | 30.28 M | ||||
Shares Outstanding | 2.75 M | ||||
Shares Owned By Insiders | 0.59 % | ||||
Shares Owned By Institutions | 37.06 % | ||||
Number Of Shares Shorted | 21.48 K | ||||
Price To Earning | (7.94) X | ||||
Price To Book | 6.31 X | ||||
EBITDA | (34.42 M) | ||||
Net Income | (36.06 M) | ||||
Cash And Equivalents | 30.05 M | ||||
Cash Per Share | 0.35 X | ||||
Total Debt | 13.38 M | ||||
Current Ratio | 1.62 X | ||||
Book Value Per Share | (7.46) X | ||||
Cash Flow From Operations | (31.84 M) | ||||
Short Ratio | 0.20 X | ||||
Earnings Per Share | (12.93) X | ||||
Target Price | 55.0 | ||||
Number Of Employees | 18 | ||||
Beta | 2.68 | ||||
Market Capitalization | 14.86 M | ||||
Total Asset | 21.12 M | ||||
Retained Earnings | (274.39 M) | ||||
Working Capital | (2.96 M) | ||||
Current Asset | 3.84 M | ||||
Current Liabilities | 840.05 K | ||||
Z Score | -23.07 | ||||
Net Asset | 21.12 M |
About Eloxx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eloxx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eloxx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eloxx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |